Search Results 11-20 of 263 for celiac disease
Research Mayo Clinic researchers are studying the diagnosis and treatments of vascular disease, including median arcuate ligament syndrome.
Mayo Clinic care providers trained in evaluating and treating vascular diseases work closely to evaluate and treat people with MALS .
Study IDs Site IRB Rochester, Minnesota: 15-007568 Sponsor Protocol Number: 15-007568 About this study The purpose of the study is to assess the connection between simvastatin metabolism by an enzyme that varies based on the state of the small intest...
Study IDs Site IRB Rochester, Minnesota: 17-005850 Sponsor Protocol Number: 17-005850 About this study The aim of this study is to the number of individuals following a gluten-free diet and possible reasons including symptoms of non-celiac...
Most people can treat celiac disease with a gluten-free diet.
Study IDs Site IRB Rochester, Minnesota: 12-009541 Jacksonville, Florida: 12-009541 Scottsdale/Phoenix, Arizona: 12-009541 NCT ID: NCT01917630 Sponsor Protocol Number: ALV003-1221 About this study To determine the effects of 12 weeks administration o...
Study IDs Site IRB Rochester, Minnesota: 17-003596 Sponsor Protocol Number: 17-003596 About this study The purpose of this study is to identify mediators-innate immune system and intestinal permeability-of acute onset gastrointestinal symptoms after ...
Medical records research - uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Celiac disease.
Study IDs Site IRB Rochester, Minnesota: 22-006404 NCT ID: NCT05425446 Sponsor Protocol Number: DQB101US About this study The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of DONQ52 in celiac...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
A generous benefactor has pledged $1 million and challenged us to raise an additional $250,000. Help us reach our goal!